WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 7 fonti

Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the University of Liverpool in the UK, and presented at the European Congress on Obesity (ECO 2026), could have an answer.

Raccontata dagizmodo.comsciencealert.comindependent.co.ukindex.hrhvg.huscientificamerican.comhindustantimes.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
sciencealert.comStai leggendo1 g fa

Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the University of Liverpool in the UK, and…

originale
independent.co.uk1 g fa

Another effect of weight loss drugs could be changing the brain, research suggests

University of Colorado Anschutz found GLP-1 drugs boost brain connectivity within months, reducing addictive behaviors and improving attention. If confirmed, GLP-1s shift from metabolic to CNS drugs, reshaping pharma pipelines and enterprise health budgets.

Leggi questa versione → originale
gizmodo.com22 h fa

Can Ozempic Treat Alcoholism? Here's What You Should Know

A first Lancet RCT (26 weeks, n=100) found semaglutide reduced alcohol consumption and heavy drinking days vs placebo. The shared dopamine mechanism implies GLP-1s could address multiple addictions, reshaping Novo Nordisk's pipeline beyond obesity.

Leggi questa versione → originale
hindustantimes.com1 h fa

Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

Leggi questa versione → originale
index.hr1 g fa

Istraživanje: Lijekovi poput Ozempica smanjuju rizik od bolesti

NOVA studija pokazuje da je smanjenje rizika od bolesti povezanih s pretilošću izravno vezano uz količinu kilograma izgubljenih pomoću GLP-1 lijekova poput Ozempica.

Leggi questa versione → originale
scientificamerican.com17 h fa

New powerful GLP-1 drugs drop a lot of weight fast. How does that affect health?

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and too fast to lose?

Leggi questa versione → originale

Timeline cronologica

  1. martedì 26 maggio 2026·gizmodo.com

    Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows

    As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.

  2. giovedì 28 maggio 2026·sciencealert.com

    Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

    Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the…

  3. giovedì 28 maggio 2026·independent.co.uk

    Another effect of weight loss drugs could be changing the brain, research suggests

    Scientists are looking to see how GLP-1 drugs may impact the brain and reshape people’s nervous systems

  4. giovedì 28 maggio 2026·index.hr

    Istraživanje: Lijekovi poput Ozempica smanjuju rizik od bolesti

    NOVA studija pokazuje da je smanjenje rizika od bolesti povezanih s pretilošću izravno vezano uz količinu kilograma izgubljenih pomoću GLP-1 lijekova poput Ozempica.

  5. venerdì 29 maggio 2026·gizmodo.com

    Can Ozempic Treat Alcoholism? Here's What You Should Know

    A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

  6. venerdì 29 maggio 2026·hvg.hu

    Egészségesebb lesz valaki a fogyást segítő csodaszerek hatására? Megszületett a válasz

    A Liverpooli Egyetem kutatói 89 718 amerikai egészségügyi adatait vizsgálva derítette ki, milyen hosszútávú hatása lehet a fogyást segítő csodaszereknek.

  7. venerdì 29 maggio 2026·scientificamerican.com

    New powerful GLP-1 drugs drop a lot of weight fast. How does that affect health?

    New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and too fast to lose?

  8. sabato 30 maggio 2026·hindustantimes.com

    Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

    GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News